About us Contacts Drug interactions: 390 212
Drug search by name

Kaletra Oral Solution and Thyrolar

Determining the interaction of Kaletra Oral Solution and Thyrolar and the possibility of their joint administration.

Check result:
Kaletra Oral Solution <> Thyrolar
Relevance: 05.01.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using ritonavir together with liotrix may decrease the effects of liotrix. Contact your doctor if you experience tiredness sluggishness, weakness, memory problems, depression, difficulty concentrating, and constipation. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR: Coadministration of ritonavir with levothyroxine may reduce serum thyroxine concentrations. The proposed mechanism is ritonavir induction of glucuronosyltransferase, which is partially responsible for the metabolic clearance of thyroxine. A case report describes an HIV-infected patient who had been stabilized on levothyroxine for several months when he presented with an enlarged thyroid, marked lethargy, and elevated thyroid indices one month after switching from triple (zidovudine, lamivudine, saquinavir) to quadruple antiretroviral therapy (stavudine, lamivudine, ritonavir, saquinavir). The condition resolved following a doubling of the levothyroxine dosage. However, due to suspected drug-induced hepatotoxicity, indinavir was eventually substituted for ritonavir and saquinavir, which enabled a decrease of the levothyroxine dosage back to the previous level.

MANAGEMENT: During coadministration with ritonavir, the possibility of a diminished therapeutic response to levothyroxine should be considered. Dosage adjustment as well as clinical and laboratory monitoring may be appropriate whenever ritonavir is added to or withdrawn from therapy.

References
  • Touzot M, Beller CL, Touzot F, Louet AL, Piketty C "Dramatic interaction between levothyroxine and lopinavir/ritonavir in a HIV-infected patient." AIDS 20 (2006): 1210-2
  • Tseng A, Fletcher D "Interaction between ritonavir and levothyroxine." AIDS 12 (1998): 2235-6
  • Sahajpal R, Ahmed RA, Hughes CA, Foisy MM "Probable interaction between levothyroxine and ritonavir: Case report and literature review." Am J Health Syst Pharm 74 (2017): 587-592
  • Berger JL, Nguyen Y, et. al "Early neuropsychological adverse events after switching from PI/r to dolutegravir could be related to hyperthyroidism in patients under levothyroxine." Antivir Ther 22 (2017): 271-2
Kaletra Oral Solution

Generic Name: lopinavir / ritonavir

Brand name: Kaletra

Synonyms: Kaletra

Thyrolar

Generic Name: liotrix

Brand name: Thyrolar, Thyrolar-1, Thyrolar-1/2, Thyrolar-1/4, Thyrolar-2, Thyrolar-3

Synonyms: n.a.

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction